Literature DB >> 18087222

ATM prevents unattended DNA double strand breaks on site and in generations to come.

Bu Yin1, Velibor Savic, Craig H Bassing.   

Abstract

Ataxia telangiectasia (A-T) is a disorder characterized by cerebellar degeneration, immunodeficiency, genomic instability and genetic predisposition to lymphoid malignancies with translocations involving antigen receptor loci. The Ataxia Telangiectasia Mutated gene encodes the ATM kinase, a central transducer of DNA damage signals. Until recently, the etiology of the lymphoid phenotype in A-T patients and the mechanisms by which ATM ensures normal repair of DNA double strand break (DSB) intermediates during antigen receptor diversification reactions remained poorly understood. Last year, Bredemeyer et al. (Nature 2006; 442:466-70) demonstrated that ATM stabilizes chromosomal V(D)J recombination DSB intermediates, facilitates DNA end joining and prevents broken DNA ends from participating in chromosome deletions, inversions and translocations. A more recent study by Callen et al. (Cell 2007; 130:63-75) highlighted the importance of ATM-mediated checkpoints in blocking the long-term persistence and transmission of un-repaired DSBs in developing lymphocytes. Collectively, these results have provided complementary mechanistic insights into ATM functions in V(D)J recombination that can account for the lymphoid tumor-prone phenotype associated with A-T.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087222     DOI: 10.4161/cbt.6.12.5336

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  3 in total

1.  Association between ATM polymorphisms and cancer risk: a meta-analysis.

Authors:  Li Shen; Zhi-Hua Yin; Yan Wan; Yue Zhang; Kun Li; Bao-Sen Zhou
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

2.  Epigenetic regulation of antigen receptor gene rearrangement.

Authors:  Salvatore Spicuglia; Joaquin Zacarias-Cabeza; Aleksandra Pekowska; Pierre Ferrier
Journal:  F1000 Biol Rep       Date:  2010-03-25

3.  ATM in breast and brain tumors: a comprehensive review.

Authors:  Mehrdad Asghari Estiar; Parvin Mehdipour
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.